Skip to main content
. 2022 Jun 6;7(3):318–327. doi: 10.1089/can.2021.0015

Table 3.

Summary for Forced Swim Test Immobility Time (Seconds) with URB597 Pretreatment

Sex Age Control
THC
CBD
THC+CBD
F value (two-way ANOVA)
p
Veh Fluo Veh Fluo Veh Fluo Veh Fluo    
Males P100–120 202.3±9.03 (n=4) 123.8±19.87 (n=5)* 164.5±7.43 (n=6) 115.6±17.48 (n=8) 164.6±8.67 (n=10) 104.9±11.06 (n=12)** 168.4±15.83 (n=5) 126.1±10.30 (n=7) F (1, 49)=33.84 <0.0001
Females P100–120 182.8±13.62 (n=4) 96.60±30.16 (n=5)* 158.1±9.32 (n=9) 68.60±10.20 (n=10)**** 153.4±17.59 (n=7) 87.91±10.16 (n=11)* 161.8±8.80 (n=6) 102.6±11.83 (n=8) F (1, 52)=56.07 <0.0001
Both sexes P100–120 192.5±8.41 (n=8) 110.2±17.62 (n=10)*** 160.7±6.19 (n=15) 89.50±10.89 (n=18)**** 160.0±8.63 (n=17) 96.78±7.59 (n=23)**** 164.8±8.229 (n=11) 113.6±8.27 (n=15)* F (1, 109)=87.36 <0.0001

Control or PCE adult progenies were treated with vehicle or fluoxetine 30 min before FST. The data residuals were normally distributed and thus ANOVA was used for statistical analysis. Three-way ANOVA analysis found PCE and treatment but not gender as significant variables. Thus, two-way ANOVA analysis with two factors: PCE and treatment (vehicle, fluoxetine) was used. There was no interaction between these two factors. The F factor refers to the fluoxetine treatment. Post hoc Bonferroni's multiple comparisons test was conducted to compare the vehicle and fluoxetine-treated groups.

*

p<0.05, **p=0.01, ***p<0.001, ****p<0.0001.

FST, forced swim test; PCE, perinatal cannabinoid exposure.